Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
Gragnano F, Mehran R, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Calabrò P, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Valgimigli M; Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration. Gragnano F, et al. Among authors: windecker s. J Am Coll Cardiol. 2023 Feb 14;81(6):537-552. doi: 10.1016/j.jacc.2022.11.041. J Am Coll Cardiol. 2023. PMID: 36754514 Free article.
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.
Valgimigli M, Mehran R, Franzone A, da Costa BR, Baber U, Piccolo R, McFadden EP, Vranckx P, Angiolillo DJ, Leonardi S, Cao D, Dangas GD, Mehta SR, Serruys PW, Gibson CM, Steg GP, Sharma SK, Hamm C, Shlofmitz R, Liebetrau C, Briguori C, Janssens L, Huber K, Ferrario M, Kunadian V, Cohen DJ, Zurakowski A, Oldroyd KG, Yaling H, Dudek D, Sartori S, Kirkham B, Escaned J, Heg D, Windecker S, Pocock S, Jüni P; SIDNEY Collaboration. Valgimigli M, et al. Among authors: windecker s. JACC Cardiovasc Interv. 2021 Feb 22;14(4):444-456. doi: 10.1016/j.jcin.2020.11.046. JACC Cardiovasc Interv. 2021. PMID: 33602441 Free article.
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
Ueki Y, Häner JD, Losdat S, Gargiulo G, Shibutani H, Bär S, Otsuka T, Kavaliauskaite R, Mitter VR, Temperli F, Spirk D, Stortecky S, Siontis GCM, Valgimigli M, Windecker S, Gutmann C, Koskinas KC, Mayr M, Räber L. Ueki Y, et al. Among authors: windecker s. Thromb Haemost. 2023 Sep 11. doi: 10.1055/a-2156-7872. Online ahead of print. Thromb Haemost. 2023. PMID: 37595625
Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial).
van Bergeijk KH, Wykrzykowska JJ, van Mieghem NM, Windecker S, Sondergaard L, Gada H, Li S, Hanson T, Deeb GM, Voors AA, Reardon MJ. van Bergeijk KH, et al. Among authors: windecker s. Am J Cardiol. 2023 Aug 1;200:78-86. doi: 10.1016/j.amjcard.2023.05.036. Epub 2023 Jun 10. Am J Cardiol. 2023. PMID: 37307783 Free article. Clinical Trial.
Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials.
Hemetsberger R, Mankerious N, Toelg R, Abdelghani M, Farhan S, Garcia-Garica HM, Allali A, Windecker S, Lefèvre T, Saito S, Kandzari D, Waksman R, Richardt G. Hemetsberger R, et al. Among authors: windecker s. Clin Res Cardiol. 2023 Sep;112(9):1278-1287. doi: 10.1007/s00392-023-02205-4. Epub 2023 Apr 16. Clin Res Cardiol. 2023. PMID: 37062047 Clinical Trial.
Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW II.
Beyene S, Tufaro V, Garg M, Gkargkoulas F, Calderon AT, Safi H, Waksman R, Windecker S, Torii R, Melaku GD, Bulant CA, Bourantas CV, Blanco PJ, Garcia-Garcia HM. Beyene S, et al. Among authors: windecker s. Cardiovasc Revasc Med. 2024 Apr;61:26-34. doi: 10.1016/j.carrev.2023.11.014. Epub 2023 Nov 25. Cardiovasc Revasc Med. 2024. PMID: 38042738
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial.
Landi A, Heg D, Frigoli E, Tonino PAL, Vranckx P, Pourbaix S, Chevalier B, Iñiguez A, Pinar E, Lesiak M, Kala P, Donahue M, Windecker S, Roffi M, Smits PC, Valgimigli M; MASTER DAPT Investigators. Landi A, et al. Among authors: windecker s. Eur J Intern Med. 2024 May 3:S0953-6205(24)00176-6. doi: 10.1016/j.ejim.2024.04.016. Online ahead of print. Eur J Intern Med. 2024. PMID: 38704291
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
Kleiman NS, Van Mieghem NM, Reardon MJ, Gada H, Mumtaz M, Olsen PS, Heiser J, Merhi W, Chetcuti S, Deeb GM, Chawla A, Kiaii B, Teefy P, Chu MWA, Yakubov SJ, Windecker S, Althouse AD, Baron SJ. Kleiman NS, et al. Among authors: windecker s. JACC Cardiovasc Interv. 2024 Apr 22;17(8):979-988. doi: 10.1016/j.jcin.2024.02.014. JACC Cardiovasc Interv. 2024. PMID: 38658126 Clinical Trial.
1,429 results